Dirk Dittmer, PhD, and colleagues have developed a model of Kaposi sarcoma could be key to the development of new drugs to treat the disease. Kaposi sarcoma is the most common cancer in people living ...

The global Kaposi’s Sarcoma market is expanding due to the HIV/AIDS prevalence, improved oncology infrastructure, and advancements in targeted and immunotherapeutic drugs. Kaposi’s Sarcoma, a tumor ...

Researchers at UNC Lineberger Comprehensive Cancer Center, after decades of research efforts, have developed a mouse model of Kaposi sarcoma that could be key to the development of new drugs to treat ...

G-doctor with older man In this case series, all 9 affected patients were Black or Hispanic. Post-transplant Kaposi sarcoma, while rare, appears to occur more often in minorities, according to a ...

Kaposi sarcoma is a slow-growing vascular tumor localized to skin, but which spreads to internal viscera in 40% of immunosuppressed post-transplant patients. Kaposi sarcoma results from either primary ...

Investigators also examined which type of immunosuppression was associated with a higher likelihood of Kaposi sarcoma. Findings presented at this month’s National Comprehensive Cancer Network (NCCN) ...

Viruses are masters of stealth, often lurking silently in our bodies. For the Kaposi sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus-8 (HHV-8), the human mouth serves as an ...

New research indicates the best available chemotherapy for Kaposi Sarcoma, which is infrequently used in Africa, is cost effective and would improve clinical outcomes. Although antiretroviral therapy ...

Background. Classic Kaposi sarcoma (cKS) is an inflammatory tumor caused by human herpesvirus 8 (HHV-8) commonly observed in elderly men of Mediterranean origin. We studied a Finnish family of 5 ...

The coronavirus disease (COVID-19) pandemic has devastated many countries, leaving more than a million people dead. Now ten months into the pandemic, more than 35.48 million people have been infected ...

Researchers have developed a model of Kaposi sarcoma that could expedite the development of new drugs to treat the disease, which is the most common cancer in people living with HIV. Researchers at ...